Clinical Trial Update: FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This document reports a completed Phase 2 trial evaluating FDG-labeled PET scans to guide chemotherapy planning in patients with stage IIIB or IV non-small cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Washington | Conditions: Malignant Pleural Effusion, Stage IIIB Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-10-21